Mutations in PI3K110δ cause impaired NK cell function partially rescued by rapamycin treatment
The Journal of Allergy and Clinical Immunology Jan 18, 2018
Ruiz-Garcia R, et al. - Heterozygous gain-of-function mutations in PI3K110 lead to lymphadenopathy, lymphoid hyperplasia, Epstein-Barr virus (EBV) and cytomegalovirus (CMV) viremia, and sinopulmonary infections. Researchers, herein, looked at the functional and phenotypic effect of PI3K110δ mutations on NK cell subsets and cytotoxic function in view of the known role of NK cell function in the control of EBV and CMV. In this study, PI3K110δ mutation-induced novel NK cell functional deficiency was described, which was a likely contributor to the severe viremia observed in these patients. Data reported that NK cell function was partially restored by rapamycin treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries